Prestige Wealth Management Group LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Prestige Wealth Management Group LLC
- $491 Million
- Q3 2025
A detailed history of Prestige Wealth Management Group LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 100 shares of ARWR stock, worth $4,126. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 165
39.39%
Holding current value
$4,126
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ARWR
# of Institutions
344Shares Held
103MCall Options Held
953KPut Options Held
263K-
Vanguard Group Inc Valley Forge, PA16MShares$662 Million0.01% of portfolio
-
Black Rock Inc. New York, NY15.7MShares$647 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.9MShares$450 Million5.14% of portfolio
-
State Street Corp Boston, MA6.4MShares$264 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.98MShares$206 Million3.21% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $4.37B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...